Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 16, Issue 1, 2011, Pages

  Eguia Del Valle, Asier ^a   Martinez Conde Llamosas, Rafael ^a   López Vicente, Jose ^a   Uribarri Etxebarria, Agurne ^a   Aguirre Urizar, José Manuel ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Cytokines; Oral ulcers; Recurrent aphthous stomatitis; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

APHTHOUS STOMATITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; SALIVA; STATISTICAL ANALYSIS;

HUMANS; RECURRENCE; SALIVA; STOMATITIS, APHTHOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78751670909     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.16.e33     Document Type: Article

References (20)

1. Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:141-7.
2. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit Rev Oral Biol Med. 1998;9:306-21.
3. Rioboo-Crespo Mdel R, Planells-del Pozo P, Rioboo-García R. Epidemiology of the most common oral mucosal diseases in children. Med Oral Patol Oral Cir Bucal. 2005;10:376-87.
4. Pedersen A, Hougen HP, Kenrad B. T-lymphocyte subsets in oral mucosa of patients with recurrent aphthous ulceration. J Oral Pathol Med. 1992;21:176-80.
5. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence Int. 2000;31:95-112.
6. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003;134:200-7.
7. Boras VV, Lukac J, Brailo V, Picek P, Kordić D, Zilić IA. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration. J Oral Pathol Med. 2006;35:241-3.
8. Natah SS, Häyrinen-Immonen R, Hietanen J, Malmström M, Konttinen YT. Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU). J Oral Pathol Med. 2000;29:19-25. (Pubitemid 30065121)
9. Tirelli AS, Colombo C, Torresani E, Cariani L, Arnaboldi E, Conese M. Validation of an automated sensitive immunoassay for quantitation of cytokines in the sputum of cystic fibrosis patients. Clin Chem Lab Med. 2007;45:108-11.
10. Berthier F, Lambert C, Genin C, Bienvenu J. Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. Clin Chem Lab Med. 1999;37:593-9.
11. Evereklioglu C, Er H, Türköz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Mediators Inflamm. 2002;11:87-93.
12. Saini A, Al-Shanti N, Stewart CE. Waste management - cytokines, growth factors and cachexia. Cytokine Growth Factor Rev. 2006;17:475-86.
13. Brabers NA, Nottet HS. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest. 2006;36:447-58.
14. Sun A, Wang JT, Chia JS, Chiang CP. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations. J Oral Pathol Med. 2006;35:111-6.
15. Eguia A, Villarroel M, Martínez-Conde R, Echebarría MA, Aguirre JM. Adamantiades-Behçet disease: an enigmatic process with oral manifestations. Med Oral Patol Oral Cir Bucal. 2006;11:E6-11.
16. García Callejo FJ, Orts Alborch MH, Morant Ventura A, Segarra Cortés P, Marco Algarra J. [Recurrent aphthous stomatitis and clinical response to pentoxifylline]. Acta Otorrinolaringol Esp. 1999;50:671-3.
17. Vujevich J, Zirwas M. Treatment of severe, recalcitrant, major aphthous stomatitis with adalimumab. Cutis. 2005;76:129-32.
18. Guimarães AL, Correia-Silva Jde F, Sá AR, Victória JM, Diniz MG, Costa Fde O, et al. Investigation of functional gene polymorphisms IL-1beta, IL-6, IL-10 and TNF-alpha in individuals with recurrent aphthous stomatitis. Arch Oral Biol. 2007;52:268-72.
19. Okada AA. Behçet's disease: general concepts and recent advances. Curr Opin Ophthalmol. 2006;17:551-6.
20. Hale S, Lightman S. Anti-TNF therapies in the management of acute and chronic uveitis. Cytokine. 2006;33:231-7.